339) PT mepolizumab EGPA https://salute.regione.emilia-romagna.it/ssr/strumenti-e-informazioni/ptr/elaborati/docptr339_pt-mepolizumab-egpa_mar2023.pdf/view https://salute.regione.emilia-romagna.it/@@site-logo/logo_rer_quadrato_bianco.png 339) PT mepolizumab EGPA DocPTR339_PT mepolizumab EGPA_mar2023.pdf — 378.2 KB
339) PT mepolizumab EGPA https://salute.regione.emilia-romagna.it/ssr/strumenti-e-informazioni/ptr/elaborati/docptr339_pt-mepolizumab-egpa_mar2023.pdf/view https://salute.regione.emilia-romagna.it/@@site-logo/logo_rer_quadrato_bianco.png 339) PT mepolizumab EGPA DocPTR339_PT mepolizumab EGPA_mar2023.pdf — 378.2 KB